🔗 Share this article

Texas Attorney General Paxton is filing a lawsuit against the makers of acetaminophen, alleging the corporations hid safety concerns that the pain reliever presented to pediatric neurological development.

The court filing arrives four weeks after President Donald Trump advocated an unproven link between using Tylenol - alternatively called paracetamol - during pregnancy and autism in offspring.

The attorney general is filing suit against J&J, which previously sold the drug, the sole analgesic suggested for pregnant women, and the current manufacturer, which presently makes it.

In a statement, he stated they "misled consumers by making money from pain and promoting medication ignoring the risks."

Kenvue says there is insufficient reliable data connecting acetaminophen to autism.

"These corporations lied for decades, knowingly endangering numerous people to line their pockets," Paxton, from the Republican party, stated.

Kenvue said in a statement that it was "deeply concerned by the dissemination of inaccurate information on the reliability of paracetamol and the potential impact that could have on the welfare of American women and children."

On its website, Kenvue also mentioned it had "continuously evaluated the pertinent research and there is insufficient valid information that demonstrates a proven link between using paracetamol and autism."

Groups representing physicians and medical practitioners concur.

ACOG has declared acetaminophen - the key substance in Tylenol - is a restricted selection for expectant mothers to address pain and elevated temperature, which can pose serious health risks if not addressed.

"In multiple decades of investigation on the use of paracetamol in gestation, zero credible investigations has successfully concluded that the use of paracetamol in any stage of gestation results in neurological conditions in offspring," the association said.

This legal action cites current declarations from the Trump administration in asserting the medication is potentially dangerous.

In recent weeks, Trump caused concern from health experts when he instructed pregnant women to "struggle intensely" not to use Tylenol when unwell.

Federal regulators then published an announcement that physicians should think about restricting the use of Tylenol, while also stating that "a direct connection" between the drug and autism spectrum disorder in young ones has remains unverified.

Health Secretary Robert F Kennedy Jr, who manages the Food and Drug Administration, had vowed in spring to conduct "comprehensive study program" that would determine the origin of autism in a matter of months.

But specialists warned that finding a unique factor of autism spectrum disorder - believed by scientists to be the result of a complicated interplay of genetic and external influences - would prove challenging.

Autism is a type of permanent neurological difference and condition that affects how people experience and interact with the surroundings, and is identified using physician assessments.

In his lawsuit, Paxton - who supports Trump who is running for federal office - alleges Kenvue and J&J "willfully ignored and tried to quiet the science" around acetaminophen and autism.

This legal action attempts to require the firms "eliminate any marketing or advertising" that states Tylenol is safe for expectant mothers.

The court case parallels the complaints of a collection of parents of young ones with autism spectrum disorder and attention deficit hyperactivity disorder who sued the makers of acetaminophen in two years ago.

The court rejected the lawsuit, stating investigations from the family's specialists was not conclusive.